← All trials
NCT07240467
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 15, 2025
- Primary completion
- Dec 15, 2028
- Completion date
- Dec 15, 2028
- First posted
- Nov 21, 2025
- Last posted
- Nov 21, 2025
- Enrollment
- 220
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Huazhong University of Science and TechnologyLead sponsor
- Hubei University of Chinese MedicineCollaborator
- Jingzhou Hospital of Traditional Chinese MedicineCollaborator
- Wuhan UniversityCollaborator
- Xiang Yang NO.1 People's HospitalCollaborator
- Huazhong University of Science and TechnologyCollaborator
- Wuhan Central HospitalCollaborator
- Huazhong University of Science and TechnologyCollaborator
- Huazhong University of Science and TechnologySponsor investigator
- Yichang Hospital of Traditional Chinese MedicineCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.